Hybrid Resistance and Virulence Plasmids in “High-Risk” Clones of Klebsiella pneumoniae, Including Those Carrying blaNDM-5

Turton, Jane; Davies, Frances; Turton, Jack; Perry, Claire; Payne, Zoë; Pike, Rachel

doi:10.3390/microorganisms7090326

Open AccessArticle

Hybrid Resistance and Virulence Plasmids in “High-Risk” Clones of Klebsiella pneumoniae, Including Those Carrying bla_NDM-5

by

Jane Turton

^1,*

,

Frances Davies

²,

Jack Turton

³,

Claire Perry

¹,

Zoë Payne

¹ and

Rachel Pike

¹

National Infection Service, Public Health England, 61, Colindale Avenue, London NW9 5EQ, UK

²

Imperial College Healthcare NHS Trust, North West London Pathology, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK

³

Independent Informatician, NW9 0TA c/o National Infection Service, Public Health England, 61, Colindale Avenue, London NW9 5EQ, UK

^*

Author to whom correspondence should be addressed.

Microorganisms 2019, 7(9), 326; https://doi.org/10.3390/microorganisms7090326

Submission received: 26 July 2019 / Revised: 2 September 2019 / Accepted: 3 September 2019 / Published: 6 September 2019

(This article belongs to the Section Medical Microbiology)

Download

Browse Figures

Review Reports Versions Notes

Abstract

:

Virulence plasmids are associated with hypervirulent types of Klebsiella pneumoniae, which generally do not carry antibiotic resistance genes. In contrast, nosocomial isolates are often associated with resistance, but rarely with virulence plasmids. Here, we describe virulence plasmids in nosocomial isolates of “high-risk” clones of sequence types (STs) 15, 48, 101, 147 and 383 carrying carbapenemase genes. The whole genome sequences were determined by long-read nanopore sequencing. The 12 isolates all contained hybrid plasmids containing both resistance and virulence genes. All carried rmpA/rmpA2 and the aerobactin cluster, with the virulence plasmids of two of three representatives of ST383 carrying bla_NDM-5 and seventeen other resistance genes. Representatives of ST48 and ST15 had virulence plasmid-associated genes distributed between two plasmids, both containing antibiotic resistance genes. Representatives of ST101 were remarkable in all sharing virulence plasmids in which iucC and terAWXYZ were missing and iucB and iucD truncated. The combination of resistance and virulence in plasmids of high-risk clones is extremely worrying. Virulence plasmids were often notably consistent within a lineage, even in the absence of epidemiological links, suggesting they are not moving between types. However, there was a common segment containing multiple resistance genes in virulence plasmids of representatives of both STs 48 and 383.

Keywords:

virulence plasmid; rmpA/rmpA2; carbapenemase; high-risk clone; Klebsiella pneumoniae; nanopore sequencing

Graphical Abstract

1. Introduction

Klebsiella pneumoniae poses a dual threat to human health; in the community, it is associated with invasive disease, which can affect young, otherwise healthy people, while in the nosocomial setting it has a marked propensity to acquire antibiotic resistance [1,2,3]. It is unusual for isolates to display both these properties, but, increasingly, resistant and virulent isolates have been reported [4,5,6]. Traditionally, “hypervirulence” has been associated only with particular types, such as capsular type K1 sequence type (ST) 23 (K1-ST23) and capsular type K2 ST86 (K2-ST86), which were generally susceptible to antibiotics, but recently, virulence elements found in these types have also been described in other STs that are strongly associated with resistance, such as STs 11, 15 and 383 [7,8,9,10]. Many of these elements are carried on a large virulence plasmid, which typically carries acquired siderophore genes (especially for aerobactin, but also for salmochelin and enterochelin), heavy metal resistance genes (coding for tellurite, silver, copper and lead resistance) and capsule up-regulation genes, rmpA and rmpA2. We have previously described a representative of ST147 carrying bla_NDM-1 which carried a hybrid virulence plasmid that not only contained the aerobactin cluster, rmpA, rmpA2, and tellurite resistance genes, but also the antibiotic resistance genes sul1, sul2, armA, dfrA5, mph(A), and aph(3′)-VIb (CM007852) [9]. Similarly, Lam et al. [11] have described representatives of ST15 carrying both virulence and resistance genes in a single plasmid, and a virulence plasmid carrying bla_KPC-2 was reported in K1 hypervirulent Klebsiella pneumoniae [12]. In such cases, selection by relevant antibiotics will also select for virulence characteristics. Sequencing of further carbapenemase-gene-positive nosocomial isolates has identified twelve more isolates carrying hybrid resistance/virulence plasmids, three carrying a plasmid containing both bla_NDM-5 and virulence genes, which we describe here.

2. Results

KpvST101_OXA-48 was isolated in June 2018 from blood from an elderly patient with septicaemia in a hospital in South East England. Typing by VNTR analysis gave a profile of 5,4,1,1,-,2,4,4,3,2,3, corresponding to ST101, confirmed from the whole genome sequence. A bla_OXA-48-like gene was detected by PCR, as were rmpA and rmpA2. The minION sequencing gave a number of fully circularised contigs corresponding to the chromosome (5453528 bp) (CP031368), the IncL/M OXA-48 plasmid (65380 bp) (CP031374) and the virulence plasmid (292699 bp) (CP031369), among others. The IncFII(K)/IncFIB(K) virulence plasmid contained rmpA, rmpA2, the aerobactin cluster (iutA, iucABD, although both iucB and iucD were truncated), copper (pcoABCDERS), silver (silCERS) and tellurite (terBCDE) resistance genes, other genes associated with hypervirulence (notably cobW, involved in cobalamin biosynthesis, luxR, coding for a quorum-sensing regulator controlling virulence gene expression, pagO, which protects bacteria from phagocytosis, shiF, promoting transfer of lysine) and antibiotic resistance genes aph(6)-Id (conferring resistance to streptomycin), bla_TEM-1B (beta-lactam resistance), mph(A) (macrolide resistance), sul1, sul2 (sulphonamide resistance) and dfrA5 (trimethoprim resistance) (Table 1, Figure 1a). Interestingly, this isolate carried pld1, coding for a phospholipase D family protein, which has been linked to hypervirulence [13], as well as the yersiniabactin cluster (irp1, irp2, ybtAEPQSTUX) in the chromosome, which also carried genes encoding resistance to beta-lactam antibiotics, fluoroquinolones and fosfomycin. It was resistant to most antibiotics tested (including amikacin, gentamicin, tobramycin, ampicillin, aztreonam, cefepime, cefotaxime, ceftazidime, ertapenem, piperacillin/tazobactam, temocillin, ceftolozane/tazobactam, ciprofloxacin and minocycline), with the exception of imipenem, colistin and ceftazidime/avibactam; there was reduced susceptibility to meropenem (MIC 8 mg/L) (Table S1). All the resistance genes detected are listed in Table 1. Two other isolates of rmpA/rmpA2-positive ST101 were sequenced, one isolated in May 2018 from a further patient from the same hospital as KpvST101_OXA-48 (Kpv_ST101_SE2_2), and the other (Kpv_ST101_L5) isolated in October 2018 from a patient in a London hospital with no known epidemiological links to the other two. Remarkably, all three isolates had virulence plasmids lacking iucC and terAWXYZ (but containing terBCDE) and carrying truncated iucB and iucD; these are the only isolates in which this has been observed (Figure 1a–c). There were fewer resistance genes in the virulence plasmid of the London isolate (mph(A), sul1, dfrA5 only) than in the other two ST101 isolates, which both carried the same complement of additional genes (Table 1). All three isolates had additional plasmids carrying bla_OXA-48.

KpvST383_NDM_OXA-48 was isolated in April 2018 from blood from a middle-aged patient with bacteraemia in a hospital in London. The patient suffered overwhelming sepsis and multi-organ failure, and subsequently died. This isolate had a VNTR profile of 3,1,5,2,0,2,3,3,4,2,3, corresponding to ST383, confirmed from the whole genome sequence. It was PCR-positive for rmpA, rmpA2, bla_NDM-like and bla_OXA-48-like. Sequencing gave several circular contigs, corresponding to the chromosome (5361371 bp) (CP034200), the OXA-48 plasmid (72057 bp) (CP034202), and a hybrid NDM/virulence plasmid (372826 bp) (CP034201). This plasmid contained the aerobactin cluster (iutA, iucABCD), rmpA/rmpA2, tellurite resistance genes terABCDEWXYZ, cobW, luxR, pagO, and shiF and resistance genes bla_NDM-5, bla_CTXM-15, bla_OXA-9, qnrS1, bla_TEM-1B, dfrA5, sul1, sul2, armA, aph(3′)-Ia, aph(3′)-VI, aac(6′)-lb, aadA1, aac(6′)-lb-cr, mph(A), mph(E), msr(E) and catA1 (all at 100% identity, with the exception of catA1 (99.11% identity)), with the resistance genes located in two distinct areas (Figure 1d). Genes conferring tetracycline resistance (tet(A)), fosfomycin resistance (fosA), quinolone resistance (oqxA, oqxB) and further beta-lactamase (bla_SHV-26) genes were located on the chromosome (Table 1). The isolate did not carry the yersiniabactin cluster, often found in an integrative conjugative element (ICE) in the chromosome. In common with KpvST101_OXA-48, it carried pld1 and fyuA on the chromosome. The virulence plasmid is highly similar to that of KpvST147L_NDM (CM007852) [9], which has 99% identity with it, but only 93% coverage, this mainly being accounted for by the stretch from approximately 60,000 to 95,000 bp in this isolate, which contains bla_NDM-5, aph(3′)-VI, qnrS1, bla_CTX-M-15, aac(6′)-Ib, aac(6’)-Ib-cr, aadA1, bla_OXA-9 and bla_TEM-1B, missing in KpvST147L_NDM. There is an IS26-like element (also referred to as IS6 family transposase) at nucleotides (nt) 66471 to 67174, and a partial copy at 90579 to 90949, among other instances of this and other insertion sequences and transposons in the sequence (Figure 2). Two further rmpA/rmpA2-positive isolates of ST383 were sequenced, separated in space and time from KpvST383_NDM_OXA-48 (Kpv_ST383_L2, isolated in 2017 in a different London hospital, and Kpv_ST383_S1, isolated in 2016 in a Scottish hospital) (Figure 1e,f). All carried the same complement of virulence/metal resistance genes, with the exception of Kpv_ST383_L2, which lacked terXY, but, in common with the others, carried the rest of the tellurite resistance cluster (terABCDEWZ). All three lacked the yersiniabactin cluster (irp1, irp2, ybtAEPQSTUX). Kpv_ST383_NDM_OXA-48 and the Scottish isolate shared the same 18 resistance genes in the virulence plasmid, including bla_NDM-5, while the second London isolate carried only aph(3’)-Ia, aadA1, sul1 and tet(B) in the virulence plasmid, the latter not found in the virulence plasmids of the other two. In contrast to the others, it carried bla_NDM-1 in a separate plasmid. All three carried bla_OXA-48 in a further plasmid. Essentially, KpvST383_NDM_OXA-48 and the Scottish isolate shared the same hybrid resistance/virulence plasmid, the latter sharing 99% coverage and 98.8% identity with the former (CP034201), despite being isolated over 2 years and hundreds of miles apart and with no known links between them. However, the virulence plasmid of Kpv_ST383_L2 shared only 74% coverage with that of Kpv_ST383_NDM_OXA-48. Both Kpv_ST383_L2 and Kpv_ST383_S1 were resistant to most antibiotics tested, including ceftazidime/avibactam; Kpv_ST383_L2 was susceptible to tigecycline (MIC 0.5 mg/L) and fosfomycin (MIC 32 mg/L), but resistant to colistin (MIC 32 mg/L), while Kpv_ST383_S1 was susceptible to colistin (MIC 1 mg/L) and fosfomycin (MIC 16 mg/L), but resistant to tigecycline (MIC 4 mg/L) (Table S1).

Three representatives of ST147 carrying virulence plasmids (Kpv_ST147B_SE1_1_NDM, Kpv_ST147_SE1_2, Kpv_ST147_L3) were sequenced (Table 1); in all three cases, the virulence plasmids were a similar size and carried the same virulence gene content and very similar resistance gene complements as each other and the previously described KpvST147L_NDM (CM007852) [9], despite being isolated in three different hospitals and over a three-year time span (Table 1; Figure 1g–j). There were potential epidemiological links between the three isolates described here, especially those from the same hospital, but not with the original isolate from 2016. All three isolates carried bla_NDM-1 in a separate IncFIB(pQil) plasmid of approximately 54 kb (e.g., CP040728), which was highly similar between the three, supporting that they may be linked (all share 99% coverage and < 99% identity with one another; they also share similarly high homology with other NDM plasmid sequences on GenBank (e.g., AP018834); Single Nucleotide Polymorphism (SNP) analysis between the Illumina-corrected chromosomal sequences of Kpv_ST147B_SE1_1_NDM and Kpv_ST147_SE1_2 also supported this (six SNPs difference). Kpv_ST147_SE1_2 and KpvST147L_NDM were susceptible only to colistin (MICs ≤ 0.5 and 1 mg/L, respectively) (Table S1).

Kpv_ST15_NDM and Kpv_ST15_NW1 were isolated in December 2016 and September 2018 from the throat and urine of patients in hospitals in London and North West England, respectively. These representatives of ST15 displayed some considerable differences in their virulence plasmids; while both contained the aerobactin cluster (iutA, iucABCD), rmpA and rmpA2, the latter carried the tellurite resistance cluster (terABCDEWXYZ), pagO and luxR, not found in the former (Figure 1k,l). These are genes that are generally found in virulence plasmids, so their absence is notable in Kpv_ST15_NDM. Moreover, Kpv_ST15_NW1 carried the copper (pcoABCDERS) and silver (silCERS) resistance genes in a second plasmid (also carrying tet(D) and bla_SHV-1), while these were carried in the virulence plasmid of Kpv_ST15_NDM (CP040595). The virulence plasmid of Kpv_ST15_NDM carried lead resistance genes (pbrABCR), not found in any of the other plasmids. Both virulence plasmids also contained a number of antibiotic resistance genes, but they were different in the two, sul1 being the only common one between them. Both isolates carried bla_NDM-1 in a separate plasmid. Both carried the yersiniabactin cluster in the chromosome, but Kpv_ST15_NDM lacked some of the mrk fimbrial genes that are commonly found in K. pneumoniae and are associated with virulence. Susceptibility testing was carried out on Kpv_ST15_NDM, which was resistant to most antibiotics tested, including tigecycline and ceftazidime/avibactam, with the exception of colistin (MIC ≤ 0.5 mg/L) and fosfomycin (MIC 16mg/L) (Table S1).

The only carbapenemase-gene-positive isolate of ST48 that we have noted carrying a virulence plasmid (KpvST48_NDM) was from a patient from the same London hospital group (L5) as three other isolates in this study and was isolated in October 2018 from a rectal screen. Surprisingly, it also had the virulence and metal resistance elements associated with virulence plasmids distributed between two different plasmids. The main virulence plasmid of 302 kb (pKpvST48_1, CM016731), of type IncFIB(Mar), contained the aerobactin cluster (iutA, iucABCD), rmpA, rmpA2 and other virulence plasmid-associated genes (e.g., cobW, luxR, pagO, shiF) (Figure 1m), while the second plasmid of 226.8 kb (pKpvST48_2, CM016732) carried the lead and silver resistance gene clusters (pcoABCDERS and silCERS). Both plasmids also carried antibiotic resistance genes (aph(3’)-Ia aph(3’)-VI aac(6’)-Ib aadA1, bla_NDM-5, bla_CTX-M-15, bla_OXA-9, bla_TEM-1B, qnrS1, aac(6’)-Ib-cr, catA in the main virulence plasmid, and tet(D) in the second one). This is therefore a further example of a virulence plasmid carrying bla_NDM-5 (in a different plasmid to those found in KpvST383_NDM_OXA-48/Kpv_ST383_S1); remarkably, the whole segment of pKpvST383L (CP034201 from KpvST383_NDM_OXA-48) containing antibiotic resistance genes including bla_NDM-5 detailed in Figure 2 is duplicated in pKpvST48_1 (CM016731); indeed, this plasmid had 84% coverage of pKpvST383L, despite being some 70 kb smaller, including a large segment (nt 106473-283838) corresponding to nt 42544 to 220502 of pKpvST383L (CP034201), which carried the resistance genes above and ended with an IS110 family transposase.

The virulence plasmids from the representatives of “high-risk” clones were compared with one another, and with pK2044 (AP006726), the virulence plasmid from a representative of K1-ST23 (NTUH-K2044) of the KpVP-1-dominant virulence plasmid type [15] (Figure 1). This showed that all the plasmids shared virulence regions with pK2044, but that those from representatives of ST101 were quite considerably different from those of representatives of STs 147 and 383, which were very similar to one another, other than obvious differences such as the extra segment (containing bla_NDM-5) in pKpvST383L (CP034201) and pKpvST383_S1 (from Kpv_ST383_S1) (Figure 1a,b) (also in pKpvST48_1). pKpvST15 (CP040595 from Kpv_ST15_NDM) was different from all the other plasmids. All the plasmids carried genes coding for plasmid transfer and various conjugal transfer proteins such as TraABDEFGIJNPUVY, suggesting that conjugative plasmid transfer is possible. Our study suggests that transfer of complete plasmids is unlikely, but that IS/transposon-bound segments of sequence containing antibiotic resistance genes may move.

In at least three of the cases described here, the isolates were associated with sepsis, supporting that they may be associated with hypervirulence. A number of others were from screening swabs; this is not a contra-indication to hypervirulence, since it is recognised that colonisation precedes infection in recognised hypervirulent types. Fortunately, the incidence of high-risk clones with virulence plasmids was still relatively low, even among submissions to the reference laboratory, which are enhanced both for carbapenemase producers and for potentially hypervirulent isolates; we have noted them since 2016, and have found a total of 40 nonduplicate isolates among some 3,600 isolates, screened up until the end of the first quarter of 2019.

3. Discussion

The high-risk clones described here (of STs 15, 48, 101, 147 and 383) are not simply gaining the virulence plasmids found in hypervirulent types, which do not generally contain antibiotic resistance genes, but carry their own versions that combine both resistance and virulence elements. The only example where a virulence plasmid in a classical hypervirulent type has been described with a resistance gene at the time of writing is the hybrid KPC-2 virulence plasmid in a hypervirulent isolate of K1-ST23, which has a conserved virulence plasmid similar to those found in other isolates of K1-ST23, but with an antibiotic resistance region flanked by two copies of IS26 [12]. The authors concluded that multiple insertion elements (IS) were responsible for mediating the plasmid recombination. Analysis by Lam et al. [16] of the virulence/resistance plasmid in our previously described representative of the high-risk clone ST147, KpvST147L_NDM, showed that it carried sequences from KpVP-1, (the dominant virulence plasmid type found in K1-ST23 hypervirulent isolates such as NTUH K2044 (AP006726.1)) (40% coverage), an IncFII tra-trb conjugative transfer region and transposons carrying antibiotic resistance genes. The presence of multiple transposons and insertion sequences was a consistent finding for all the isolates described here; for example, there are seven (plus a truncated version) copies of IS26-like insertion sequences in pKpvST383, six in pKpvST147L, and four in pKpvST101 (as defined by comparison with nucleotides 1–717 of KU984333). It therefore seems likely that these hybrid plasmids have been created by IS-mediated recombination. It is important to recognise the existence of hybrid virulence and resistance plasmids, so that an antibiotic is not chosen inadvertently that selects for isolates carrying virulence plasmids. The combination of an NDM gene and virulence elements in the same plasmid, as seen in KpvST383_NDM_OXA-48, Kpv_ST383_S1 and KpvST48_NDM is particularly alarming. In several cases described here, the clinical outcome was clearly consistent with enhanced virulence, in contrast to that described previously where the isolate (KpvST147L_NDM) was from a rectal screen. Another study describing carbapenemase-gene-positive representatives of ST15 carrying a virulence plasmid (of approximately 178 kb and carrying rmpA2 and the iutAiucABCD aerobactin gene cluster) found that the isolates were not hypervirulent based on assays looking for survival in neutrophils and killing of Galleria mellonella and that all the affected patients recovered [17]. The authors concluded that further studies were needed to understand the relationship between the hypervirulent phenotype, carriage of the pLVPK-like virulence plasmid and capsular type. However, representatives of ST11 carrying a virulence plasmid showed enhanced survival in neutrophils and killed 100% of G. mellonella; these isolates were responsible for fatal infections, and the authors concluded that the hypervirulence was due to acquisition of a 170 kb pLVPK-like virulence plasmid by classic ST11 carbapenem-resistant K. pneumoniae strains [8]. Another study links three glycosyltransferases encoded by the cps gene cluster, GT-1, GT-2 and WcaJ, with virulence [18]. We note the presence of wcaJ (and glycosyltransferases) in the cps gene cluster of KpvST383_NDM_OXA-48 and KpvST147B_SE1_1_NDM, but not in those of KpvST48_NDM, Kpv_ST15_NDM or KpvST101_OXA-48.

While some of the hybrid resistance/virulence plasmids described here were similar, each ST was nevertheless associated with a different plasmid, suggesting that there is an IS-mediated mechanism for combining these genes in these plasmids. In one instance there was clearly a shared antibiotic resistance region in the virulence/resistance plasmids of isolates of different types (STs 383 and ST48), again supporting IS-mediated recombination. The existence of hybrid virulence and resistance plasmids requires enhanced surveillance, especially since it is occurring in high-risk clones that are already adept at acquiring resistance genes, if potentially untreatable invasive infections are to be avoided.

4. Materials and Methods

Isolates were submitted to the laboratory from hospitals in the United Kingdom for typing and cross-infection investigation, and/or susceptibility determination. They were identified as potentially hypervirulent by detection of rmpA and/or rmpA2 in a multiplex PCR seeking capsular types K1, K2, K5, K20, K54 and K57, rmpA, rmpA2 and wcaG, among other targets [9]. Typing was by Variable Number Tandem Repeat (VNTR) analysis at 11 loci [9], while detection of carbapenemase genes was carried out in-house by the submitting hospital. Representative isolates that were PCR-positive for rmpA/rmpA2, belonged to high-risk clones (identified by VNTR typing) and in which a carbapenemase gene(s) had been detected were selected for this study. Isolates were sequenced on a minION Mk1B, following DNA extraction using a GeneJet genomic DNA kit (ThermoFisher, Loughborough, United Kingdom) and library preparation using a Rapid Barcoding Kit SQK-RBK004 (Oxford Nanopore Technologies, Oxford, United Kingdom). The barcoded libraries of up to nine isolates were pooled, concentrated using Ampure XP beads (Beckman Coulter, High Wycombe, United Kingdom) and run on a FLO-MIN106 (R9 version) flowcell using minKnow software with local basecalling. Barcodes were identified and removed using Guppy barcode software available from Oxford Nanopore technologies and reads for each barcode assembled using miniasm 0.2-r168-dirty [19], followed by three iterations of correction with Racon 1.3.1 [20]. Illumina sequencing was also carried out on six isolates, as described previously, and the short-read sequences used to correct the minION assemblies using ten iterations of Racon. Sequences were submitted to GenBank under BioProject PRJNA483246 and BioSamples SAMN09729079 (KpvST101_OXA-48) (accession numbers CP031368-CP031375), SAMN10409888 (KpvST383_NDM_OXA-48) (accession numbers CP034200-CP034202), SAMN11793480 (KpvST48_NDM) (accession numbers VCEE00000000; CM016731-CM016736), SAMN11793565 (KpvST15_NDM) (accession numbers CP040593-CP04599) and SAMN11835544 (KpvST147B_SE1_1_NDM) (accession numbers CP040724-CP040731). The minION fastq files of all the remaining isolates (and the Illumina fastqs, where available) were submitted to the Sequence Read Archive (SRA) accession numbers SAMN12212724 (KpvST101_SE2_2), SAMN12216748 (Kpv_ST101_L5), SAMN12216749 (Kpv_ST147_SE1_2), SAMN12216750 (Kpv_ST147_L3), SAMN12221326 (Kpv_ST383_L2), SAMN12221327 (Kpv_ST383_S1) and SAMN12221328 (Kpv_ST15_NW1). Although greater than 99% accurate, the minION sequences have some additional/missing bases and therefore are not completely accurate, but have the huge advantage of facilitating complete assemblies. Virulence plasmids were compared with that of a previously described isolate of ST147 (KpvST147L_NDM) (CM007852) and with that in NTUH-K2044, a representative of “hypervirulent” K1-ST23 (AP006726). Sizes of plasmids were confirmed by pulsed-field gel electrophoresis (PFGE), as described by Barton et al. [21], following digestion of agarose-embedded DNA plugs in 100 µL 1 × S1 nuclease buffer containing 0.1 U/µL S1 nuclease (Thermofisher, Loughborough, United Kingdom) (Figure S1). PFGE conditions were 6 V/cm for 30 h at 12 °C, with initial and final switch times of 1 s and 50 s.

MICs were determined by agar dilution and interpreted using EUCAST breakpoints [15]. Resistance genes and plasmid replicon types were detected using ResFinder and PlasmidFinder, respectively, on the Center for Genomic Epidemiology website [22,23]. Sequence types were determined from the Pasteur Institute Klebsiella pneumoniae MLST website (available online: https://bigsdb.pasteur.fr/cgi-bin/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef&page=sequenceQuery).

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/2076-2607/7/9/326/s1.

Author Contributions

Conceptualization, J.T. (Jane Turton); Formal analysis, J.T. (Jack Turton); Investigation, J.T. (Jane Turton), F.D., C.P., Z.P. and R.P.; Writing—original draft, J.T. (Jane Turton); Writing—review & editing, F.D., J.T. (Jack Turton), C.P., Z.P. and R.P.

Funding

No specific funding was received for this work. Typing, detection of virulence genes and susceptibility determinations were carried out as part of the routine work of the laboratory.

Acknowledgments

We are grateful to colleagues in hospital laboratories for referring these isolates and to the Genomic Services and Development Unit at PHE for carrying out Illumina sequencing.

Conflicts of Interest

The authors declare no conflict of interest.

References

Gomez-Simmonds, A.; Uhlemann, A.C. Clinical implications of genomic adaptation and evolution of carbapenem-resistant Klebsiella pneumoniae. J. Infect. Dis. 2017, 215, S18–S27. [Google Scholar] [CrossRef]
Holt, K.E.; Wertheim, H.; Zadoks, R.N.; Baker, S.; Whitehouse, C.A.; Dance, D.; Jenney, A.; Connor, T.R.; Hsu, L.Y.; Severin, J.; et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. USA 2015, 112, E3574–E3581. [Google Scholar] [CrossRef]
Shon, A.S.; Bajwa, R.P.; Russo, T.A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: A new and dangerous breed. Virulence 2013, 4, 107–118. [Google Scholar] [CrossRef]
Lee, C.R.; Lee, J.H.; Park, K.S.; Jeon, J.H.; Kim, Y.B.; Cha, C.J.; Jeong, B.C.; Lee, S.H. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: Epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front. Cell. Infect. Microbiol. 2017, 7, 483. [Google Scholar] [CrossRef]
Roulston, K.J.; Bharucha, T.; Turton, J.F.; Hopkins, K.L.; Mack, D.J.F. A case of NDM-carbapenemase producing hypervirulent Klebsiella pneumoniae Sequence Type 23 from the United Kingdom. JMM Case Rep. 2018, 5, e005130. [Google Scholar] [CrossRef]
Becker, L.; Kaase, M.; Pfeifer, Y.; Fuchs, S.; Reuss, A.; von Laer, A.; Sin, M.A.; Korte-Berwanger, M.; Gatermann, S.; Werner, G. Genome-based analysis of carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008–2014. Antimicrob. Resist. Infect. Control. 2018, 7, 62. [Google Scholar] [CrossRef]
Andrade, L.N.; Vitali, L.; Gaspar, G.G.; Bellissimo-Rodrigues, F.; Martinez, R.; Darini, A.L. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J. Clin. Microbiol. 2014, 52, 2530–2535. [Google Scholar] [CrossRef]
Gu, D.; Dong, N.; Zheng, Z.; Lin, D.; Huang, M.; Wang, L.; Chan, E.W.; Shu, L.; Yu, J.; Zhang, R.; et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: A molecular epidemiological study. Lancet Infect. Dis. 2018, 18, 37–46. [Google Scholar] [CrossRef]
Turton, J.F.; Payne, Z.; Coward, A.; Hopkins, K.L.; Turton, J.A.; Doumith, M.; Woodford, N. Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and ‘non-hypervirulent’ types ST147, ST15 and ST383. J. Med. Microbiol. 2018, 67, 118–128. [Google Scholar] [CrossRef]
Huang, Y.H.; Chou, S.H.; Liang, S.W.; Ni, C.E.; Lin, Y.T.; Huang, Y.W.; Yang, T.C. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan. J. Antimicrob. Chemother. 2018, 73, 2039–2046. [Google Scholar] [CrossRef]
Lam, M.M.C.; Wyres, K.L.; Wick, R.R.; Judd, L.M.; Fostervold, A.; Holt, K.E.; Löhr, I.H. Convergence of virulence and MDR in a single plasmid vector in MDR Klebsiella pneumoniae ST15. J. Antimicrob. Chemother. 2019, 74, 1218–1222. [Google Scholar] [CrossRef]
Dong, N.; Lin, D.; Zhang, R.; Chan, E.W.; Chen, S. Carriage of bla_KPC-2 by a virulence plasmid in hypervirulent Klebsiella pneumoniae. J. Antimicrob. Chemother. 2018, 73, 3317–3321. [Google Scholar] [CrossRef]
Lery, L.M.; Frangeul, L.; Tomas, A.; Passet, V.; Almeida, A.S.; Bialek-Davenet, S.; Barbe, V.; Bengoechea, J.A.; Sansonetti, P.; Brisse, S.; et al. Comparative analysis of Klebsiella pneumoniae genomes identifies a phospholipase D family protein as a novel virulence factor. BMC Biology 2014, 12, 41. [Google Scholar] [CrossRef]
Sullivan, M.J.; Petty, N.K.; Beatson, S.A. Easyfig: A genome comparison visualizer. Bioinformatics 2011, 27, 1009–1010. [Google Scholar] [CrossRef]
European Committee on Antimicrobial Susceptibility Testing: Clinical Breakpoints. Available online: http://www.eucast.org/clinical_breakpoints/ (accessed on 2 September 2019).
Lam, M.M.C.; Wyres, K.L.; Judd, L.M.; Wick, R.R.; Jenney, A.; Brisse, S.; Holt, K.E. Tracking key virulence loci encoding aerobactin and salmochelin siderophore synthesis in Klebsiella pneumoniae. Genome Med. 2018, 10, 77. [Google Scholar] [CrossRef]
Shu, L.; Dong, N.; Lu, J.; Zheng, Z.; Hu, J.; Zeng, W.; Sun, Q.; Chan, E.W.; Zhou, H.; Hu, F.; et al. Emergence of OXA-232 carbapenemase-producing Klebsiella pneumoniae that carries a pLVPK-like virulence plasmid among elderly patients in China. Antimicrob. Agents Chemother. 2019, 3, e02246-18. [Google Scholar] [CrossRef]
Cai, R.; Wang, G.; Le, S.; Wu, M.; Cheng, M.; Guo, Z.; Ji, Y.; Xi, H.; Zhao, C.; Wang, X.; et al. Three capsular polysaccharide synthesis-related glucosyltransferases, GT-1, GT-2 and WcaJ, are associated with virulence and phage sensitivity of Klebsiella pneumoniae. Front. Microbiol. 2019, 10, 1189. [Google Scholar] [CrossRef]
Li, H. Minimap and miniasm: Fast mapping and de novo assembly for noisy long sequences. Bioinformatics 2016, 32, 2103–2110. [Google Scholar] [CrossRef]
Vaser, R.; Sović, I.; Nagarajan, N.; Šikić, M. Fast and accurate de novo genome assembly from long uncorrected reads. Genome Res. 2017, 27, 737–746. [Google Scholar] [CrossRef] [Green Version]
Barton, B.M.; Harding, G.P.; Zuccarelli, A.J. A General Method for Detecting and Sizing Large Plasmids. Anal. Biochem. 1995, 226, 235–240. [Google Scholar] [CrossRef]
Zankari, E.; Hasman, H.; Cosentino, S.; Vestergaard, M.; Rasmussen, S.; Lund, O.; Aarestrup, F.M.; Larsen, M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012, 67, 2640–2644. [Google Scholar] [CrossRef]
Carattoli, A.; Zankari, E.; Garcia-Fernandez, A.; Voldby Larsen, M.; Lund, O.; Villa, L.; Aarestrup, F.M.; Hasman, H. PlasmidFinder and pMLST: In silico detection and typing of plasmids. Antimicrob. Agents Chemother. 2014, 58, 3895–3903. [Google Scholar] [CrossRef]

Figure 1. Comparison of the virulence plasmids found in (a) KpvST101_OXA-48 (pKpvST101, CP031369), (b) Kpv_ST101_L5, (c) Kpv_ST101_SE2_2, (d) KpvST383_NDM_OXA-48 (pKpvST383L, CP034201), (e) Kpv_ST383_S1 (pKpvST383_S1), (f) Kpv_ST383_L2, (g) KpvST147L_NDM (pKpvST147L, CM007852), (h) Kpv_ST147B_SE1_1_NDM (pKpvST147B, CP040726), (i) Kpv_ST147_SE1_2, (j) Kpv_ST147_L3, (k) Kpv_ST15_NDM (pKpvST15, CP040595), (l) Kpv_ST15_NW1, (m) Kpv_ST48_NDM ((pKpvST48_1, CM016731). Sequences are shown starting from iucA in the aerobactin cluster, with aerobactin genes (iutA, iucABCD) coloured yellow, rmpA and rmpA2 coloured orange, other virulence gene-associated genes (cobW, hemin, lysozyme inhibitor, shiF, luxR, pagO, SAM-dependent methyltransferase (SAM-dmt)) crimson, bla_NDM-5 purple, other antibiotic resistance genes royal blue, tellurite resistance genes (terABCDEWXYZ) in dark grey, copper resistance genes (pcoABCDERS) in gold, silver resistance genes (silCERS) in silver, lead resistance genes (pbrABCR) in brown and genes encoding various Tra conjugal transfer proteins in green. IS26-like elements are marked in pink. Colour blocks above the lines indicate forward sequences, while those below the line show sequences in the opposite orientation. The red line under each sequence shows BLAST alignments with pK2044 (the virulence plasmid from NTUH2044, AP006726). The dark blue line shows BLAST alignments with pKpvST147L (CM007852 from KpvST147_NDM). Kpv_ST15_NW1 and Kpv_ST48_NDM both carried a further plasmid with the pcoABCDERS and silCERS genes.

Figure 2. Genes encoded in the region of nt 66471 to 93154 of CP034201, the virulence plasmid of KpvST383_NDM_OXA-48, which includes bla_NDM-5 (coloured purple). Other antibiotic resistance genes are shown in blue, while transposons are shown in pink. This same sequence of genes was also found in pKpvST48_1 of Kpv_ST48_NDM (nt 130384 to 156980 of CM016731). Abbreviations are: nt, nucleotide; TAT, twin-arginine translocation pathway signal sequence domain; Ble-MBL, bleomycin-binding protein. Figure created using Easyfig software [14].

Table 1. Summary of virulence and resistance gene characteristics of thirteen representatives of high-risk clones carrying hybrid virulence/resistance plasmids. All isolates were subjected to nanopore sequencing; six isolates were also subjected to Illumina sequencing, and the Illumina-corrected sequences are described below. Plasmids are described by their GenBank accession numbers or the “utg” contig number from the assembly, ‘c’ after the number indicates a circular contig.

Isolate	Virulence Plasmid	Other Virulence Factors (Chromosome)	Antibiotic Genes in Virulence Plasmid	Other Resistance Genes	Hospital (Code), Date and Source of Isolation	Clinical Manifestation	Comments
KpvST101_OXA-48 Illumina corrected sequence	plasmid pKpvST101 CP031369 292699 bp rmpA, rmpA2, (iutA, iucABD, (iucB and iucD truncated), pcoABCDERS, silCERS terBCDE, cobW, luxR, pagO, shiF	fyuA, kfuABC, irp1, irp2, ybtAEPQSTUX, mrkABCDFHIJ, pld1	aph(6)-Id, aph(3’)-Ib, bla_TEM-1Bmph(A), sul1, sul2 and dfrA5	Chromosome blaSHV-28, bla_CTX-M-15, oqxA, oqxB, fosA plasmid CP031374 65380 bp bla_OXA-48 plasmid CP031372 210661 bp armA, msr(E), mph(E) plasmid CP031373 43670 bp blaSHV-28, qnrS1	South_East_2 (SE2) June 2018 blood	septicaemia	no iucC no terAWXYZ
Kpv_ST101_SE2_2	utg000004c (294751 bp) iutA, iucABD (iucB and iucD truncated), rmpA, rmpA2, terBCDE, pcoABCDERS, silCERS, FecA, cobW, luxR, pagO, shiF	fyuA, kfuABC, irp1, irp2, ybtAEPQSTUX, pld1, mrkABCDFHIJ	aph(6)-Id, aph(3’)-Ib, bla_TEM-1B, mph(A), sul1, sul2 and dfrA5	Chromosome blaSHV-28, bla_CTX-M-15, oqxA, oqxB, fosA, utg16c; 65307 bp bla_OXA-48 utg31c bla_CTX-M-15, armA, msr(E), mph(E) utg27c blaSHV-28, qnrS1	South_East_2 (SE2) May 2018 sputum	chest infection	no iucC no terAWXYZ
Kpv_ST101_L5	utg00035c (267754 bp) iutA, iucABD (iucB and D truncated), rmpA, rmpA2, terBCDE, pcoABCDERS, silCERS, FecA, cobW, luxR, pagO, shiF	fyuA, irp1, irp2, kfuABC, ybtAEPQSTUX, pld1, mrkABCDFHIJ	mph(A), sul1, dfrA5	Chromosome blaSHV-28, bla_CTX-M-15, oqxA, oqxB, fosA utg000020c armA, msr(E), mph(E) utg000037c bla_OXA-48 utg000108c blaSHV-28, qnrS1	London_5 (L5) October 2018 rectal screen	screen	no iucC no terAWXYZ
KpvST383_NDM_OXA-48 Illumina corrected sequence	plasmid pKpvST383L CP034201 372826 bp iutA, iucABCD, rmpA/rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF	mrkABCDFHIJ, pld1	bla_NDM-5, bla_CTXM-15, bla_OXA-9, qnrS1, bla_TEM-1B, dfrA5, catA1, sul1, sul2, armA, aph(3′)-1a, aph(3′)-VI, aac(6′)-lb, aadA1, aac(6′)-lb-cr, mph(A), mph (E) and msr(E)	blaSHV-26, oqxA, oqxB, fosA, mph(A), catA1, tet(A) plasmid CP034202 72057 bp aph(6)-Id, aph(3’)-Ib, aph(3’)-VIb, aph(3’)-Ib, blaCTX-M-14b, bla_OXA-48	London_5 (L5) April 2018 blood	bacteraemia, sepsis, multi-organ failure and death	no yersiniabactin
Kpv_ST383_L2	utg000003c (294,141) iutA, iucABCD, rmpA/rmpA2, terABCDEWZ, cobW, luxR, pagO, shiF	mrkABCDFHIJ, pld1	aph(3’)-Ia, aadA1, sul1, tet(B)	blaSHV-26, oqxA, oqxB, fosA, sul1 utg000002c (110455 bp) rmtC, bla_NDM-1 utg000011c (105957 bp) aph(’’)-Ib, aph(6)-Id, aac(6’)-Ib3, aadA1, bla_OXA-48 bla_CTX-M-14b, bla_OXA-9, aac(6’)-Ib-cr	London_2 (L2) April 2017 blood	sepsis	Not got yersiniabactin ybt cluster, irp1,2) or terXY
Kpv_ST383_S1	utg000038c (374430 bp) (pKpvST383_S1) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, pagO, shiF, luxR	mrkABCDFHIJ, pld1	aadA1, aac(6’)-Ib aph(3’)-Ia, armA, aph(3’)-VI, bla_TEM-1B, bla_OXA-9, bla_CTX-M-15, bla_NDM-5, aac(6’)-Ib-cr, qnrS1, msr(E), mph(E), mph(A), catA1, sul1, sul2, dfrA5	blaSHV-26, oqxA, oqxB, fosA, mph(A), catA1, tet(A) utg000039c (72122 bp) aph(3’)-Ib, aph(3’)-VIb, aph(3’)-Ib, aph(6)-Id, bla_OXA-48, bla_CTX-M-14b	Scotland1 (S1) Feb 2016 rectal swab	No information; screening swab	terXY present, no ybt irp1,2 cluster Ex Egypt (in hospital in Cairo)
KpvST147L_NDM previously described [9]; Illumina corrected	plasmid pKpvST147L CM007852.1 343,282 bp iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF	mrkABCDFHIJ	sul1, sul2, armA, dfrA5, mph(A), msr(E), mph(E), aph(3’)-Ia	bla_NDM-1, aph(3’)-Ia. aac(6’)-Ib, aadA1 blaTEM-1A, blaOXA-9, blaCTX-M-15, blaSHV-67, qnrS1, aac(6’)-Ib-cr, oqxA, oqxB, fosA	London_5 (L5) January 2016 rectal swab	screening swab
KpvST147B_SE1_1_NDM Illumina corrected sequence	plasmid pKpvST147B CP040726 (339117 bp) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF	fyuA, mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX	sul1, sul2, armA, dfrA5, mph(A), msr(E), mph(E) bla_CTX-M-15	aac(6’)-Ib, aadA1, blaSHV-67, bla_OXA-9, bla_TEM-1A, oqxA oqxB, aac(6’)-Ib-cr fosA plasmid CP040728 53950 bp aac(6’)-Ib-cr, aph(3’)-VI, bla_OXA-1, bla_CTX-M-15, bla_NDM-1, qnrS1, catB3, ARR-3, sul1	South_East_1 (SE1) January 2019 rectal swab	no information, screening swab
Kpv_ST147_SE1_2 Illumina corrected sequence	utg000005c (338588 bp) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF	fyuA, mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX	armA, mphA, sul1, sul2, dfrA5, bla_CTX-M-15, mph(E), msr(E)	Chromosome oqxA, oqxB, fosA, blaSHV-67 utg000020c; 53949 bp, bla_NDM-1, sul1, aph(3’)-VI, catB3, ARR-3, qnrS1, aac(6’)-Ib-cr, blaOXA-1 utg000007c 39671 bp aadA1, aac(6’)-Ib, blaTEM-1A, bla_OXA-9, aac(6’)-Ib-cr	South_East_1 (SE1) December 2018 urine	patient died
Kpv_ST147_L3	utg000005c (339641 bp) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF	fyuA, mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX	armA, aph(3’)-Ia, bla_CTX-M-15, mph(A), mph(E), msr(E), sul1, sul2, dfrA5	Chromosome blaSHV-67, oqxA, oqxB, fosA utg000004c; 53895 bp bla_NDM-1, aac(6’)-Ib-cr, aph(3’)-VI, bla_OXA-1, bla_CTX-M-15, aac(6’)-Ib-cr, qnrS1, catB3, ARR-3, sul1	London_3 (L3) January 2019 not given	No information
Kpv_ST15_NDM (L6) Illumina corrected sequence	plasmid pKpvST15 CP040595 277162 bp iutA, iucABCD, rmpA, rmpA2, pbrABCR, pcoABCDERS, silCERS, cobW, shiF	fyuA, irp1, irp2, ybtAEPQSTUX, kfuABC, mrkA(B),	aac(6’)-Ib3, rmtC, bla_CMY-6, aac(6’)-Ib-cr, sul1	bla_CTX-M-15, blaSHV-28, oqxA, oqxB, fosA, plasmid CP040598 106597 bp bla_NDM-1, sul1	London_6 (L6) 19.12.16 Throat swab	screen	mrkB truncated (17% only), no mrkCDFHIJ, no tellurite resistance genes, pagO or luxR
Kpv_ST15_NW1	utg000104c (340,126 bp): iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF 2nd plasmid: utg000031c 222308 bp: pcoABCDERS, silCERS	irp1, irp2, mrkABCDFHIJ, ybtAEPQSTUX, kfuABC	armA, aph(3’)-Ia, msr(E), mph(E), mph(A), sul1, sul2, dfrA5 utg000031c: blaSHV-1, tet(D)	aph(3’)-VI, bla_NDM-1, blaSHV-28, qnrS1 (utg000030l), oqxA, oqxB (utg000001l),	North_West_1 (NW1) September 2018 urine	No information	pcoABCDERS, silCERS, tet(D) in 2nd plasmid
Kpv_ST48_NDM Illumina corrected sequence	plasmid pKpvST48_1 CM016731 302,220 bp iutA, iucABCD, rmpA, rmpA2, cobW, luxR, pagO, shiF 2nd plasmid KpvST48_2 CM016732 226800 bp pcoABCDERS, silCERS, FecA	mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX, fyuA	CM016731: aph(3’)-Ia aph(3’)-VI aac(6’)-Ib aadA1, bla_NDM-5, bla_CTX-M-15, bla_OXA-9, bla_TEM-1B, qnrS1, aac(6’)-Ib-cr, catA1 CM016732: tet(D)	aadA2, aph(3’)-Ia, blaSHV-172, blaCTX-M-14b, oqxA, oqxB, fosA, mph(A), sul1, dfrA12	London_5 (L5) October 2018 rectal screen	No information; screening swab	pcoABCDERS, silCERS, FecA, tet(D) in CM016732, no tellurite resistance genes, patient ex Egypt

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Turton, J.; Davies, F.; Turton, J.; Perry, C.; Payne, Z.; Pike, R. Hybrid Resistance and Virulence Plasmids in “High-Risk” Clones of Klebsiella pneumoniae, Including Those Carrying bla_NDM-5. Microorganisms 2019, 7, 326. https://doi.org/10.3390/microorganisms7090326

AMA Style

Turton J, Davies F, Turton J, Perry C, Payne Z, Pike R. Hybrid Resistance and Virulence Plasmids in “High-Risk” Clones of Klebsiella pneumoniae, Including Those Carrying bla_NDM-5. Microorganisms. 2019; 7(9):326. https://doi.org/10.3390/microorganisms7090326

Chicago/Turabian Style

Turton, Jane, Frances Davies, Jack Turton, Claire Perry, Zoë Payne, and Rachel Pike. 2019. "Hybrid Resistance and Virulence Plasmids in “High-Risk” Clones of Klebsiella pneumoniae, Including Those Carrying bla_NDM-5" Microorganisms 7, no. 9: 326. https://doi.org/10.3390/microorganisms7090326

APA Style

Turton, J., Davies, F., Turton, J., Perry, C., Payne, Z., & Pike, R. (2019). Hybrid Resistance and Virulence Plasmids in “High-Risk” Clones of Klebsiella pneumoniae, Including Those Carrying bla_NDM-5. Microorganisms, 7(9), 326. https://doi.org/10.3390/microorganisms7090326

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu